Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Kaplan Meyer

<< Previous

Bullboard Posts

Next >>

Post by enriquesuaveon Oct 11, 2024 5:23pm

276 Views

Post# 36263384

Kaplan Meyer

Kaplan Meyer Seems to indicate that 450 day CR rate is 28,5%. 2 years is at 25.5% and 3 years should be at 21.4% CR rate! Outstanding long term data IMHO! After only one treatment. On,y 53 % of patients treated to date have received 2 treatments, the rest only One treatment. AA please!

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals